Banque Cantonale Vaudoise Decreases Stake in Mettler-Toledo International, Inc. $MTD

Banque Cantonale Vaudoise cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 39.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,260 shares of the medical instruments supplier’s stock after selling 837 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Mettler-Toledo International were worth $1,589,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of MTD. Geneos Wealth Management Inc. lifted its position in Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares in the last quarter. Baird Financial Group Inc. boosted its holdings in Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC boosted its holdings in Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after purchasing an additional 125 shares during the last quarter. Cerity Partners LLC grew its stake in shares of Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after buying an additional 392 shares during the period. Finally, AXA S.A. grew its stake in shares of Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on MTD shares. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. JPMorgan Chase & Co. lowered their price objective on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Citigroup reduced their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Morgan Stanley decreased their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus price target of $1,408.55.

Mettler-Toledo International Stock Up 1.6%

Shares of MTD opened at $1,263.76 on Friday. The company has a market capitalization of $25.54 billion, a price-to-earnings ratio of 29.64, a price-to-earnings-growth ratio of 2.59 and a beta of 1.27. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The stock has a 50 day moving average price of $1,178.25 and a 200 day moving average price of $1,293.75.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.